Dupilumab: Direct Cost and Clinical Evaluation in Patients with Atopic Dermatitis

Table 1

Annual dispensing number and cost of Dupilumab in moderate-to-severe atopic dermatitis in the period January 2019 and December 2021.

Gender	2019		2020		2021
	Annual expenditure	Drug dispensing number	Annual expenditure	Drug dispensing number	Annual expenditure	Drug dispensing number
Females	9.151,99 €	20	117.134,45 €	256	119.687,75 €	288
Males	15.558,38 €	34	141.841,73 €	310	186.374,34 €	450
Total	24.710,37 €	54	258.976,2 €	566	306.062,09 €	738